Apixaban has been associated with prolongation of the international normalized ratio (INR),
but data surrounding the extent of elevation and its clinical significance are limited. Due to …

Padesát let ovládal oblast perorální antikoagulační léčby warfarin. Lék, který významně
zlepšil prognózu pacientů s fibrilací síní, žilními trombózami a náhradami srdečních chlopní …

Non-vitamin K oral anticoagulant (NOAC) therapy may be inappropriate if prescription was
incorrect, the patient's physiological parameters change, or interacting concomitant …

The article reports on the rising use of antithrombotics in case of children. Antiplatelets are
generally used in arterial thromboses which include large number of platelets while …

BACKGROUND Rivaroxaban is a non-vitamin K antagonist oral anticoagulant that does not
require coagulation monitoring based on current recommendations. Our goal is to explore …

Aim Reducing or reversing the toxicity effects of new oral anticoagulants is an important
question. The purpose of the present study is to evaluate the effect of lipid emulsion (LE) and …

Dear Editor, A 47-year-old woman was admitted to the emergency room 1.5 h after
attempting suicide with 400 mg (20 tablets) rivaroxaban, prescribed for left leg deep vein …

Apixaban is widely used to prevent and manage thromboembolic disease. Due to it being
fairly new in the market, we are still understanding its complete risk profile. We present a …

Apixaban is widely used to prevent and manage thromboembolic disease. Due to it being
fairly new in the market, we are still understanding its complete risk profile. We present a …

In attempting to identify drugs that they believe to be hazardous to small children, Koren and
Nachmani rely heavily on subjective and theoretical considerations. The updated list of 'one …